Medicare to Cover CAR-T Therapy for Leukemia, Lymphoma

THURSDAY, Aug. 8, 2019 -- A breakthrough gene therapy will be covered for certain types of lymphoma and leukemia, Medicare says. Chimeric antigen receptor T-cell (CAR-T) therapy boosts a patient ' s own immune cells to fight cancer and can cost...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news